With periodontitis considered to be a major chronic inflammatory disease, methodologies to manage the disease process have changed to balance the anti microbial approach with an anti inflammatory direction. Systems will be investigated to include risk assessment data collection. Evidence will be provided for developing "realistic" non-surgical/surgical therapies and the respective reevaluation with emphasis on "new" anti inflammatory systems including micro-ultrasonics and laser technology, and nutra-ceuticals as probiotics and anti-oxidants. Attention will be placed on patient engagement in the process for compliance including user friendly oral hygiene devices.

  

About the Speaker: Samuel B. Low, D.D.S., M.S., M.Ed., Professor Emeritus, University of Florida, College of Dentistry; Associate faculty member of the Pankey Institute with 30 years of private practice experience in periodontics and implant placement. He is a graduate of University of Texas Dental Branch at Houston. He is also a Diplomate of the American Board of Periodontology and Past President of the American Academy of Periodontology. His research interests include ultrasonics, osseous grafting, anti oxidants and electronic data collection systems and is affiliated with the Florida Probe Corporation. He was selected "Dentist of the Year" by the Florida Dental Association, Distinguished Alumnus by the University Of Texas Dental School and the recipient of the Gordon Christensen Lecturer Recognition Award. He is Past President of the Florida Dental Association and a former Trustee to the American Dental Association.